PsyProtix

PsyProtix is a precision psychiatry company focused on developing therapies for treatment-resistant depression (TRD) and other mental health indications. PsyProtix is leveraging a precision psychiatry approach to develop metabolomics-based biomarkers for stratifying patients with treatment-resistant depression (TRD) and other mental health indications. By identifying patient subgroups with distinct metabolic profiles, PsyProtix will test mechanism-based therapeutic approaches to improve overall outcomes.